SK hynix Lists ADRs on NASDAQ, Elevating Global Status at the Heart of Capital Markets

SK hynix Lists ADRs on NASDAQ, Elevating Global Status at the Heart of Capital Markets

SK hynix commences ADR trading with an "Opening Bell" ceremony attended by SK Group Chairman Chey Tae-won and key executive leadership Company aims to expand investor base and solidify leadership as a "Core AI Partner" in the memory market CEO Kwak...

EACON Lists on HKEX, Accelerating Global Autonomous Mining Growth

EACON Lists on HKEX, Accelerating Global Autonomous Mining Growth

HONG KONG, July 8, 2026 /PRNewswire/ -- EACON Group Co., Ltd. ("EACON", Stock Code: 07687.HK) has officially been listed on the Hong Kong Stock Exchange (HKEX), marking a significant milestone in the company's development and its next phase of...

E Fund (HK) HKEX Tech 100 Index ETF (3456) Lists Today

E Fund (HK) HKEX Tech 100 Index ETF (3456) Lists Today

First ETF Tracking the HKEX Tech 100 Index – One-Click Access to Six Key Tech Innovation Themes HONG KONG, June 26, 2026 /PRNewswire/ -- E Fund Management (Hong Kong) Company Limited ("E Fund HK") today announced the official listing and...

STARTRADER Lists SpaceX (SPCX) CFD Days After Historic Nasdaq Debut

STARTRADER Lists SpaceX (SPCX) CFD Days After Historic Nasdaq Debut

Rapid addition of the largest IPO in market history underscores the broker's commitment to meeting trader demand in real time DUBAI, UAE, June 24, 2026 /PRNewswire/ -- STARTRADER has added SPCX CFD (Space Exploration Technologies Corp.) to its...

Vedanta Completes Historic Demerger, Lists Four New Companies on BSE and NSE

Vedanta Completes Historic Demerger, Lists Four New Companies on BSE and NSE

MUMBAI, India, June 24, 2026 /PRNewswire/ -- Vedanta Group marked a defining milestone in Indian corporate history with the successful listing of four newly demerged companies on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE). The...

China's Leading Innovative Drug Developer for Allergic and Autoimmune Diseases LongBio Pharma Lists on Hong Kong Stock Exchange

China's Leading Innovative Drug Developer for Allergic and Autoimmune Diseases LongBio Pharma Lists on Hong Kong Stock Exchange

SHANGHAI, June 5, 2026 /PRNewswire/ -- LongBio Pharma, a portfolio company of Qiming Venture Partners and a leading innovative drug developer for allergic and autoimmune diseases in China, listed on the Hong Kong Stock Exchange on June 5, 2026...

Time to Shine: CSOP Gold ETF (3030.HK) Lists on HKEX Today

Time to Shine: CSOP Gold ETF (3030.HK) Lists on HKEX Today

HONG KONG, April 21, 2026 /PRNewswire/ -- CSOP Gold ETF (3030.HK) has listed on HKEX today (21 April 2026) with an initial AUM size of about US$720 million (about HK$5.6 billion), making it Hong Kong's largest local physical gold ETF to date [1] ....

Precision Proteomics Leader Alamar Biosciences Lists on NASDAQ

Precision Proteomics Leader Alamar Biosciences Lists on NASDAQ

SHANGHAI, April 20, 2026 /PRNewswire/ -- Alamar Biosciences, a portfolio company of Qiming Venture Partners and a global leader in precision proteomics, successfully listed on the NASDAQ Stock Exchange on April 17th, 2026, Beijing Time. Alamar...

Chinese Edge AI Chip Leader Axera Lists on Hong Kong Stock Exchange

Chinese Edge AI Chip Leader Axera Lists on Hong Kong Stock Exchange

SHANGHAI, Feb. 11, 2026 /PRNewswire/ -- Axera, a portfolio company of Qiming Venture Partners and a leading Chinese edge AI chip company, successfully listed on the Hong Kong Stock Exchange on February 10th, 2026, Beijing time, becoming the first of...

ARTERY-KY (6907) Officially Lists on TPEx, Strengthening High-Performance MCU Technologies for Global Smart Applications

ARTERY-KY (6907) Officially Lists on TPEx, Strengthening High-Performance MCU Technologies for Global Smart Applications

TAIPEI, Jan. 30, 2026 /PRNewswire/ -- ARTERY-KY (6907) was officially listed on the Taipei Exchange (TPEx) yesterday (January 29), marking a significant milestone in the company's development and injecting new momentum into Taiwan's capital market....

  • 1
  • 2
  • menu
    menu